Sibel Health Inc.
6
1
1
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 65/100
16.7%
1 terminated/withdrawn out of 6 trials
75.0%
-11.5% vs industry average
0%
0 trials in Phase 3/4
67%
2 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (6)
Advancing the Science of Pediatric Interstage Home Monitoring
Role: collaborator
Effect of ANNE One-Wellue Device Array Use on Staff Bedside Vital Sign Measurement Activity
Role: collaborator
ANNE Diagnostic Agreement With Home Sleep Testing
Role: collaborator
Assessing Innovative Wireless and Wearable Sensors for Continuous Blood Pressure Measurement in Obese Pregnant Women
Role: lead
Comparative Study of the ANNE™ One System to Diagnose Obstructive Sleep Apnea
Role: collaborator
Accuracy of Pulse Oximeter With Profound Hypoxia
Role: lead
All 6 trials loaded